|
🐜
|
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
18 auth.
Apoorva Mulay,
B. Konda,
G. Garcia,
C. Yao,
S. Beil,
J. Villalba,
C. Koziol,
C. Sen,
Arunima Purkayastha,
J. Kolls,
...
D. Pociask,
P. Pessina,
Julio Sainz de Aja,
Carolina Garcia-de-Alba,
Carla F. Kim,
B. Gomperts,
V. Arumugaswami,
B. Stripp
|
6 |
2021 |
6
🐜
|
|
🐜
|
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters
35 auth.
Lisa Miorin,
C. Mire,
S. Ranjbar,
A. Hume,
Jessie Huang,
N. Crossland,
K. White,
M. Laporte,
Thomas Kehrer,
V. Haridas,
Elena Moreno,
Aya Nambu,
S. Jangra,
Anastasija Cupic,
M. Déjosez,
...
Kristine A Abo,
Anna E. Tseng,
R. Werder,
R. Rathnasinghe,
T. Mutetwa,
I. Ramos,
Julio Sainz de Aja,
Carolina Garcia de Alba Rivas,
M. Schotsaert,
Ronald B. Corley,
J. Falvo,
A. Fernández-Sesma,
Carla F. Kim,
J. Rossignol,
A. Wilson,
T. Zwaka,
D. Kotton,
E. Mühlberger,
A. García-Sastre,
A. Goldfeld
|
3 |
2022 |
3
🐜
|
|
🐢
|
Nanog regulates Pou3f1 expression and represses anterior fate at the exit from pluripotency
12 auth.
Antonio Barral,
I. Rollan,
Héctor Sánchez-Iranzo,
W. Jawaid,
C. Badía-Careaga,
S. Menchero,
...
Manuel Gomez-Rodriguez,
C. Torroja,
F. Sánchez-Cabo,
B. Göttgens,
M. Manzanares,
Julio Sainz de Aja
|
0 |
2019 |
0
🐢
|
